Pharmaceuticals

Cardiology

Cardiovascular diseases represent the main commitment of Menarini thanks to the company’s experience of more than 30 years in making innovative cardiovascular drugs available for the patients. Menarini is focused on treating the most widespread diseases of the cardiovascular area and on the prevention and reduction of risk factors associated with chronic conditions like hypertension and angina with the commitment to help patients in restoring their quality of life. Basing on the company’s vision, Menarini has focused its energy also on the research to optimise existing therapeutic tools and on creating new, innovative drugs and therapeutic aids.

chronic stable angina

Chronic stable angina

Chronic stable angina is the main manifestation of stable coronary artery disease and arises from a mismatch between myocardial oxygen supply and demand...

READ MORE

heart failure

Heart failure

Heart failure is considered as the whole set of signs and symptoms developed when the heart loses its ability to pump blood around the body efficiently...

READ MORE

hypertension

Hypertension

Before speaking about hypertension, we should know that our blood pressure is recorded by two numbers: the systolic blood pressure (SBP), higher number...

READ MORE

myocardial infarction

Myocardial infarction

Myocardial infarction is a serious medical emergency in which the supply of blood to the heart is suddenly blocked, usually by a blood clot. It is considered...

READ MORE

Pharmaceuticals

Innovation & Research

We are highly committed to developing effective solutions to address the global threat associated with antimicrobial resistance. Discover more about our R&D projects in the anti-infectives area.

Read More